APOA5 and myeloid sarcoma: The present study not only discloses the exceptionally higher prevalence of MS in APOA5 −1131CC carriers than in TC and CC carriers, but also suggests that identification of carriers of the C allele of the APOA5 −1131 polymorphism may be helpful for preventive care for MS.